Browse stocks · Browse sectors · Healthcare · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

NSE RESEARCH WORKSPACE

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

OverviewFinancial StatementsQuant ScoreForensic Accounting+

Price1Y

Company Overview

Glenmark Pharmaceuticals Ltd is classified in Pharmaceuticals.

Market Cap: ₹ 61,146.8 Cr.
Price in snapshot: ₹ 2,166.6
ROE: 14.07 %
ROCE: 35.66 %
Dividend Yield: 0.11 %

Snapshot updated 22 July 2026. Figures are not live quotes.

Research coverage

Concall documents: transcript for Q1 FY27, dated 5 August 2026.
Annual-report coverage: FY2025.
Company exchange-filing catalog coverage.

Browse concall documents · Browse exchange filings